Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Genomics
  4. Volume 26, Issue 1
  5. Article
Volume 26, Issue 1
  • ISSN: 1389-2029
  • E-ISSN: 1875-5488

Abstract

Biobanks are necessary resources for the storage and management of human biological materials, such as biofluids, tissues, cells, or nucleotides. They play a significant role in the development of new treatments and the advancement of basic and translational research, especially in the field of biomarkers discovery and validation. The regulatory landscape for biobanks, which is necessary to safeguard both privacy and scientific discoveries, exhibits significant heterogeneity across different countries and regions. This article outlines the standards that modern biobanks should fulfill in the European Union (EU), including general, structural, resource, process, and quality requirements. Special attention is given to the importance of transparency and donor consent following the General Data Protection Regulation (GDPR) and the ISO 20387:2018, the international standard specifies general requirements for biobanks. A dedicated section covers the preparation of donor information materials, emphasizing consent for research involvement and personal data processing. The delicate balance between donors' privacy rights and scientific research promotion is also discussed, with a focus on the patenting and economic use of biological material-derived inventions and data. Considering these factors, it would be warranted to refine legal frameworks and foster interdisciplinary collaboration to ethically and responsibly expand biobanking.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cg/10.2174/0113892029313697240729091922
2024-07-30
2024-12-26

  • From This Site

    /content/journals/cg/10.2174/0113892029313697240729091922
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PaskalW. PaskalA.M. DębskiT. GryziakM. JaworowskiJ. Aspects of modern biobank activity – comprehensive review.Pathol. Oncol. Res.201824477178510.1007/s12253‑018‑0418‑429728978
     [Google Scholar]
  2. CoppolaL. CianfloneA. GrimaldiA.M. IncoronatoM. BevilacquaP. MessinaF. BaseliceS. SoricelliA. MirabelliP. SalvatoreM. Biobanking in health care: Evolution and future directions.J. Transl. Med.201917117210.1186/s12967‑019‑1922‑331118074
     [Google Scholar]
  3. GeeS. OliverR. CorfieldJ. GeorghiouL. YuilleM. Biobank Finances: A socio-economic analysis and review.Biopreserv. Biobank.201513643545110.1089/bio.2015.003026697914
     [Google Scholar]
  4. GramatiukS. HuppertzB. Types of Biobanks.Biobanks in Low- and Middle-Income Countries: Relevance, Setup and Management. SargsyanK. HuppertzB. GramatiukS. ChamSpringer International Publishing2022172010.1007/978‑3‑030‑87637‑1_3
     [Google Scholar]
  5. ZakrzewskiW. DobrzyńskiM. SzymonowiczM. RybakZ. Stem cells: Past, present, and future.Stem Cell Res. Ther.20191016810.1186/s13287‑019‑1165‑530808416
     [Google Scholar]
  6. ReichelJ. SlokenbergaS. TzortzatouO. GDPR and Biobanking: Individual Rights, Public Interest and Research Regulation Across Europe.ChamSpringer International Publishing2021
     [Google Scholar]
  7. SolbakkJ.H. HolmS. HofmannB. The Ethics of Research Biobanking.United StatesSpringer US200910.1007/978‑0‑387‑93872‑1
     [Google Scholar]
  8. BonizziG. ZattoniL. FuscoN. Biobanking in the digital pathology era.Oncol. Res.202129422923310.32604/or.2022.02489237303941
     [Google Scholar]
  9. MichalakE.E. CheungI.W. WillisE. HoleR. PomeroyB. MortonE. KananiS.S. BarnesS.J. Engaging diverse patients in a diverse world: The development and preliminary evaluation of educational modules to support diversity in patient engagement research.Res. Involv. Engagem.2023914710.1186/s40900‑023‑00455‑037420307
     [Google Scholar]
  10. SieckCJ NicksSE SalemJ Addressing Equity and Social Needs: The New Frontier of Patient Engagement Research.Adv Health Care Manag2022212100810.1108/S1474‑823120220000021008
     [Google Scholar]
  11. ChenW CoombesBJ LarsonNB Recent advances and challenges of rare variant association analysis in the biobank sequencing era.Front Genet202213101494710.3389/fgene.2022.1014947
     [Google Scholar]
  12. Rodriguez LlorianE. KopacN. WalijiL.A. BorleK. DragojlovicN. ElliottA.M. LyndL.D. A Rapid review on the value of biobanks containing genetic information.Value Health20232691286129510.1016/j.jval.2023.02.01736921900
     [Google Scholar]
  13. MercurioB. UpretiP.N. Patent term extension and test data protection obligations: Identifying the gap in policy, research, and practice of implementing free trade agreements.J. Law Biosci.2023102lsad01710.1093/jlb/lsad01737476179
     [Google Scholar]
  14. de KokJ.W.T.M. de la HozM.Á.A. de JongY. BrokkeV. ElbersP.W.G. ThoralP. CastillejoA. TrenorT. CastellanoJ.M. BronchaloA.E. MerzT.M. FaltysM. CasaresC. JiménezA. RequejoJ. GutiérrezS. CurtoD. RätschG. PeppinkJ.M. DriessenR.H. SijbrandsE.J.G. KompanjeE.J.O. GirbesA.R.J. BarberanJ. VaronaJ.F. VillaresP. van der HorstI.C.C. XuM. CeliL.A. van BusselB.C.T. BorratX. A guide to sharing open healthcare data under the General Data Protection Regulation.Sci. Data202310140410.1038/s41597‑023‑02256‑237355751
     [Google Scholar]
  15. HaratiMD WilliamsRR MovassaghiM An introduction to starting a Biobank.Methods Mol Biol2019189771610.1007/978‑1‑4939‑8935‑5_2
     [Google Scholar]
  16. AnnaratoneL. De PalmaG. BonizziG. SapinoA. BottiG. BerrinoE. MannelliC. ArcellaP. Di MartinoS. SteffanA. DaidoneM.G. CanzonieriV. ParodiB. ParadisoA.V. BarberisM. MarchiòC. Basic principles of biobanking: From biological samples to precision medicine for patients.Virchows Arch.2021479223324610.1007/s00428‑021‑03151‑034255145
     [Google Scholar]
  17. GilleF. VayenaE. BlasimmeA. Future-proofing biobanks’ governance.Eur. J. Hum. Genet.202028898999610.1038/s41431‑020‑0646‑432424324
     [Google Scholar]
  18. RadhakrishnanR. ChandrashekarC. ShettyS.S. Evolution of biobanks and ethical governance for the emerging applications in biomedical research.J. Oral Maxillofac. Pathol.202226443343910.4103/jomfp.jomfp_478_2237082047
     [Google Scholar]
  19. BorisovaA.L. PokrovskayaM.S. MeshkovA.N. MetelskayaV.A. ShatalovaA.M. DrapkinaO.M. ISO 20387 biobanking standard. Analysis of requirements and experience of implementation.Russian Clin Lab Diagn202065958759210.18821/0869‑2084‑2020‑65‑9‑587‑59233245646
     [Google Scholar]
  20. MoutthamL. GarrisonS.J. ArcherD.L. CastelhanoM.G. A Biobank’s Journey: Implementation of a quality management system and accreditation to ISO 20387.Biopreserv. Biobank.202119316317010.1089/bio.2020.006833147079
     [Google Scholar]
  21. InvernizziM. de SireA. VenetisK. CignaE. CardaS. BorgM. CisariC. FuscoN. Quality of life interventions in breast cancer survivors: State of the art in targeted rehabilitation strategies.Anticancer. Agents Med. Chem.202222480181010.2174/187152062166621060909560234151769
     [Google Scholar]
  22. BonizziG CapraM CassiC Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management.J Vis Exp20221896395010.3791/63950
     [Google Scholar]
  23. EvansCR NievesCI EricksonN Intersectional inequities in the birthweight gap between twin and singleton births: A random effects MAIHDA analysis of 2012-2018 New York City birth data.Soc Sci Med202333111606310.1016/j.socscimed.2023.116063
     [Google Scholar]
  24. NansumbaH SsewanyanaI TaiM Role of a regulatory and governance framework in human biological materials and data sharing in National Biobanks: Case studies from Biobank Integrating Platform, Taiwan and the National Biorepository, Uganda.Wellcome Open Res.20194171310.12688/wellcomeopenres.15442.2
     [Google Scholar]
  25. SalokannelM. TarkkalaH. SnellK. Legacy samples in Finnish biobanks: Social and legal issues related to the transfer of old sample collections into biobanks.Hum. Genet.201913811-121287129910.1007/s00439‑019‑02070‑031620872
     [Google Scholar]
  26. Motta-MurguiaL. Saruwatari-ZavalaG. Mexican Regulation of Biobanks.J. Law Med. Ethics2016441586710.1177/107311051664419927256124
     [Google Scholar]
  27. BonizziG ZattoniL CapraM Standard operating procedures for biobank in oncology.Front Mol Biosci2022996731010.3389/fmolb.2022.967310
     [Google Scholar]
  28. PonchiettiL. Muralha AntunesN.F. Utrilla FornalsA. TalvingP. GarceaA. Roldón GoletM. García DominguezM. Yanez BenitezC. Use of visual media in the era of European Union’s General Data Protection Regulation: A practice-oriented guideline.Cirugía Española (English Edition)202199640441110.1016/j.cireng.2021.02.00534130812
     [Google Scholar]
  29. MascalzoniD. BentzenH.B. Budin-LjøsneI. BygraveL.A. BellJ. DoveE.S. FuchsbergerC. HveemK. MayrhoferM.T. MeravigliaV. O’BrienD.R. PattaroC. PramstallerP.P. RakicV. RossiniA. ShabaniM. SvantessonD.J.B. TomasiM. UrsinL. WjstM. KayeJ. Are requirements to deposit data in research repositories compatible with the European Union’s General Data Protection Regulation?Ann. Intern. Med.2019170533233410.7326/M18‑285430776795
     [Google Scholar]
  30. EdemekongP.F. AnnamarajuP. HaydelM.J. Health Insurance Portability and Accountability Act.StatPearls. StatPearls Publishing Copyright © 2023.Treasure Island, FLStatPearls Publishing LLC2023
     [Google Scholar]
  31. DameriM CirmenaG RaveraF Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol.Crit Rev Oncol Hematol2023218510396310.1016/j.critrevonc.2023.103963
     [Google Scholar]
  32. AgnieszkaM-W.J. Sign in to continue with EndNote.2023Available From: https://www.myendnoteweb.com/EndNoteWeb.html
  33. HillsL. Working well with the informal leaders in your practice.J. Med. Pract. Manage.201430319720025807624
     [Google Scholar]
  34. ChróścickaA. PaluchA. KalaszczyńskaI. Szabłowska-GadomskaI. Biobank personnel — the key to its success.Altern. Lab. Anim.202250427528110.1177/0261192922111397635862125
     [Google Scholar]
  35. WilliamsRR GuptaD YongWH Orientation and training of New Biobank Personnel.Methods Mol Biol20191897516310.1007/978‑1‑4939‑8935‑5_6
     [Google Scholar]
  36. CicekMS OlsonJE Mini-review of laboratory operations in Biobanking: Building biobanking resources for translational research.Front Public Health2020836210.3389/fpubh.2020.00362
     [Google Scholar]
  37. GeigerJ. FuchsJ. StarkeM. NeumannM. BaberR. NussbeckS.Y. KiehntopfM. SpechtC. IlligT. HummelM. JahnsR. GBA/GBN-position on the feedback of incidental findings in biobank-based research: Consensus-based workflow for hospital-based biobanks.Eur. J. Hum. Genet.20233191066107210.1038/s41431‑023‑01299‑836732662
     [Google Scholar]
  38. FrascarelliC. BonizziG. MusicoC.R. ManeE. CassiC. Guerini RoccoE. FarinaA. ScarpaA. LawlorR. Reggiani BonettiL. CaramaschiS. EccherA. MarlettaS. FuscoN. Revolutionizing cancer research: The impact of artificial intelligence in digital biobanking.J. Pers. Med.2023139139010.3390/jpm1309139037763157
     [Google Scholar]
  39. EccherA ScarpaA Dei TosAP Impact of a centralized archive for pathology laboratories on the health system.Pathol Res Pract202334515448810.1016/j.prp.2023.154488
     [Google Scholar]
  40. EccherA. Dei TosA.P. ScarpaA. L’ImperioV. MunariE. TronconeG. NaccaratoA.G. SeminatiD. PagniF. Cost analysis of archives in the pathology laboratories: From safety to management.J. Clin. Pathol.2023761065966310.1136/jcp‑2023‑20903537532289
     [Google Scholar]
  41. DiazZ. Aguilar-MahechaA. PaquetE.R. BasikM. OrainM. CamliogluE. ConstantinA. BenlimameN. BachvarovD. JannotG. SimardM.J. ChabotB. GologanA. KlinckR. Gagnon-KuglerT. LespéranceB. SamsonB. KavanP. AlcindorT. DalfenR. LanC. ChabotC. BuchananM. PrzybytkowskiE. QureshiS. RousseauC. SpatzA. TêtuB. BatistG. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.Mod. Pathol.201326111413142410.1038/modpathol.2013.8123743930
     [Google Scholar]
  42. Matera-WitkiewiczA KrupińskaM SitekP Quality management in polish biobanking network-current status before the implementation of unified and harmonized integrated quality management system.Front Med (Lausanne)2021878029410.3389/fmed.2021.780294
     [Google Scholar]
  43. PillaiS CalvertJ FoxE Practical considerations for laboratories: Implementing a holistic quality management system.Front Bioeng Biotechnol202210104010310.3389/fbioe.2022.1040103
     [Google Scholar]
  44. IndrakusumaR. KalkmanS. KoelemayM.J.W. BalmR. WillemsD.L. Context-relative norms determine the appropriate type of consent in clinical biobanks: Towards a potential solution for the discrepancy between the general data protection regulation and the european data protection board on requirements for consent.Sci. Eng. Ethics20202663271328410.1007/s11948‑020‑00271‑933048326
     [Google Scholar]
  45. MüllerA. HovanecJ. JosephsB. WiethegeT. BrüningT. BehrensT. A two-level biobank data protection concept for project-driven human sample collections.Biopreserv. Biobank.201917431231810.1089/bio.2018.011230882231
     [Google Scholar]
  46. CritselisE. Impact of the general data protection regulation on clinical proteomics research.Proteomics Clin. Appl.2019132180019910.1002/prca.20180019930706988
     [Google Scholar]
  47. Di IorioC.T. CarinciF. OderkirkJ. SmithD. SianoM. de MarcoD.A. de LusignanS. HamalainenP. BenedettiM.M. Assessing data protection and governance in health information systems: A novel methodology of Privacy and Ethics Impact and Performance Assessment (PEIPA).J. Med. Ethics20202020medethics-2019-10594810.1136/medethics‑2019‑10594832220868
     [Google Scholar]
  48. Tzortzatou-NanopoulouO. AkyüzK. GoisaufM. Ethical, legal, and social implications in research biobanking: A checklist for navigating complexity.Dev World BioethHoboken, New JerseyWiley202310.1111/dewb.12411
     [Google Scholar]
  49. DirectorS. Informed consent, price transparency, and disclosure.Bioethics202337874174710.1111/bioe.1320637506217
     [Google Scholar]
  50. SanchiniV. BonizziG. DisalvatoreD. MonturanoM. PeceS. VialeG. Di FioreP.P. BonioloG. A trust-based pact in research biobanks. from theory to practice.Bioethics201630426027110.1111/bioe.1218426307361
     [Google Scholar]
  51. SanchiniV. MarelliL. MonturanoM. BonizziG. PeruzzottiG. OrecchiaR. PravettoniG. A comprehensive ethics and data governance framework for data-intensive health research: Lessons from an Italian cancer research institute.Account. Res.202311810.1080/08989621.2023.224888437608751
     [Google Scholar]
  52. SmitJ.R. MostertM. van der GraafR. Specific measures for data-intensive health research without consent: A systematic review of soft law instruments and academic literature.Eur. J. Hum. Genet.2023202301471-010.1038/s41431‑023‑01471‑037848609
     [Google Scholar]
  53. ParvinenL. AlamäkiA. HallikainenH. MäkiM. Exploring the challenges of and solutions to sharing personal genomic data for use in healthcare.Health Informatics J.202329110.1177/1460458223115218536651319
     [Google Scholar]
  54. Krekora-ZającD MarciniakB PawlikowskiJ. Recommendations for creating codes of conduct for processing personal data in biobanking based on the GDPR art.40.Front Genet20211271161410.3389/fgene.2021.711614
     [Google Scholar]
  55. BatheO.F. McGuireA.L. The ethical use of existing samples for genome research.Genet. Med.2009111071271510.1097/GIM.0b013e3181b2e16819745750
     [Google Scholar]
  56. GoreC. MorinS. RøttingenJ.A. KienyM.P. Negotiating public-health intellectual property licensing agreements to increase access to health technologies: An insider’s story.BMJ Glob. Health202389e01296410.1136/bmjgh‑2023‑01296437669799
     [Google Scholar]
  57. McG.L. Trade-Related aspects of intellectual property rights flexibilities and public health: Implementation of compulsory licensing provisions into National Patent Legislation.Milbank Q2023101941280130310.1111/1468‑0009.12669
     [Google Scholar]
  58. BabyarJ. Trade, intellectual property, and the public health bearing.Health Syst. (Basingstoke)202312112313210.1080/20476965.2022.206246036926369
     [Google Scholar]
  59. MarrK. PhanP. The valorization of non-patent intellectual property in academic medical centers.J. Technol. Transf.20204561823184110.1007/s10961‑020‑09827‑033012983
     [Google Scholar]
/content/journals/cg/10.2174/0113892029313697240729091922
Loading
The Regulatory Landscape of Biobanks In Europe: From Accreditation to Intellectual Property
Curr. Genomics 26, 15 (2025); https://doi.org/10.2174/0113892029313697240729091922
/content/journals/cg/10.2174/0113892029313697240729091922
/content/journals/cg/10.2174/0113892029313697240729091922
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Biobanks; biological materials; biomarkers; clinical studies; translational research; transparency and consent

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test